IN2012DN02860A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN02860A IN2012DN02860A IN2860DEN2012A IN2012DN02860A IN 2012DN02860 A IN2012DN02860 A IN 2012DN02860A IN 2860DEN2012 A IN2860DEN2012 A IN 2860DEN2012A IN 2012DN02860 A IN2012DN02860 A IN 2012DN02860A
- Authority
- IN
- India
- Prior art keywords
- vaccine
- vibrio cholerae
- cell
- lnaba
- etec
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 abstract 4
- 241000602423 Vibrio cholerae O1 Species 0.000 abstract 2
- 206010008631 Cholera Diseases 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/107—Vibrio
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27235109P | 2009-09-16 | 2009-09-16 | |
| PCT/SE2010/050996 WO2011034495A1 (en) | 2009-09-16 | 2010-09-16 | Vaccine against cholera and enterotoxigenic e. coli (etec) diarrhea |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN02860A true IN2012DN02860A (pt) | 2015-06-19 |
Family
ID=43758898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2860DEN2012 IN2012DN02860A (pt) | 2009-09-16 | 2010-09-16 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9511133B2 (pt) |
| EP (1) | EP2477649B1 (pt) |
| JP (2) | JP2013505017A (pt) |
| KR (1) | KR101722802B1 (pt) |
| CN (1) | CN102630166B (pt) |
| AU (1) | AU2010296065B2 (pt) |
| CA (1) | CA2774335C (pt) |
| DK (1) | DK2477649T3 (pt) |
| ES (1) | ES2616912T3 (pt) |
| HU (1) | HUE031957T2 (pt) |
| IN (1) | IN2012DN02860A (pt) |
| PL (1) | PL2477649T3 (pt) |
| PT (1) | PT2477649T (pt) |
| WO (1) | WO2011034495A1 (pt) |
| ZA (1) | ZA201202710B (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201212010D0 (en) | 2012-07-05 | 2012-08-22 | Sigmoid Pharma Ltd | Formulations |
| CN102824632A (zh) * | 2012-09-12 | 2012-12-19 | 北京民海生物科技有限公司 | 霍乱弧菌o1群多糖结合疫苗、其制备方法及应用 |
| RU2535122C1 (ru) * | 2013-11-06 | 2014-12-10 | Федеральное казенное учреждение здравоохранения "Российский научно-исследовательский противочумный институт "Микроб" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека ("РосНИПЧИ "Микроб") | Способ получения холерогена-анатоксина |
| RU2563620C2 (ru) * | 2014-08-05 | 2015-09-20 | Федеральное казенное учреждение здравоохранения "Российский научно-исследовательский противочумный институт "Микроб" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека ("РосНИПЧИ "Микроб") | Способ получения таблетированной формы холерной бивалентной химической вакцины |
| CN108431230B (zh) * | 2015-12-14 | 2023-02-21 | 默沙东和惠康基金会合资的希勒曼实验室私人有限公司 | 用于产生经纯化重组霍乱毒素B(rCTB)的新方法及其制剂 |
| EP3450556B1 (en) | 2016-04-27 | 2022-03-23 | Osaka University | Peptide inhibiting colonization by pathogenic bacteria, and colonization inhibitor including same |
| US20210085775A1 (en) | 2017-12-15 | 2021-03-25 | Valneva Sweden Ab | Methods and composition for preventing and/or treating cancer |
| WO2021005623A1 (en) * | 2019-07-08 | 2021-01-14 | Msd Wellcome Trust Hilleman Laboratories Pvt. Ltd. | A vaccine formulation for protection against enterotoxigenic e. coli (etec) and cholera |
| WO2021105061A1 (en) | 2019-11-25 | 2021-06-03 | Gotovax Ab | Whole cell vaccines and methods of production thereof |
| WO2022074061A1 (en) | 2020-10-07 | 2022-04-14 | Valneva Sweden Ab | Cholera vaccine formulation |
| WO2022117823A1 (en) * | 2020-12-04 | 2022-06-09 | Valneva Se | Methods and compositions for preventing and/or treating autoimmune diseases |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5882653A (en) * | 1983-03-04 | 1999-03-16 | The University Of Maryland System | Vibrio cholerae 01 (CVD111) and non-01 (CVD112 and CVD112RM) serogroup vaccine strains, methods of making same and products thereof |
| US5330753A (en) * | 1987-04-29 | 1994-07-19 | President And Fellows Of Harvard College | Cholera vaccines |
| AU4660893A (en) * | 1992-07-06 | 1994-01-31 | President And Fellows Of Harvard College | Deletion mutants as vaccines for cholera |
| US6203799B1 (en) * | 1993-07-01 | 2001-03-20 | Presidents And Fellows Of Harvard College | Vibrio cholerae mutants which are soft-agar penetration defective and lack a functional CtxA subunit |
| JP3098401B2 (ja) * | 1995-07-12 | 2000-10-16 | 株式会社エルティーティー研究所 | 経鼻投与用製剤 |
| WO2000067784A1 (en) * | 1999-05-10 | 2000-11-16 | University Of Maryland, Baltimore | Bacteriophage isolated from bacterial genomes and extrachromosomal elements and methods of use thereof |
| US7270961B2 (en) * | 2002-04-16 | 2007-09-18 | Hui Sunny Chang | In vitro assay for quantitating secreted antibodies in lymphocyte supernatant for evaluation of vaccine or antigen induced specific antibody secretion from ex vivo circulating antibody-secreting lymphocytes |
| US20060171966A1 (en) * | 2002-08-30 | 2006-08-03 | Centre For Health And Population Research | Variants of vibrio cholerae 01 biotype e1 tor with attributes of classical biotype |
| CU23334A1 (es) * | 2003-03-20 | 2008-12-24 | Inst Finlay | Vacuna de vibrio cholerae inactivada en tabletas |
| US20060099229A1 (en) * | 2004-11-05 | 2006-05-11 | Universiti Sains Malaysia | Vibrio cholerae strains VCUSM1 and VCUSM4, method of producing same, and vaccine derivatives thereof |
| EP1543836A1 (en) * | 2003-12-17 | 2005-06-22 | Berna Biotech AG | Recombinant Vibrio cholerae strain and vaccine comprising said strain |
| US8642046B2 (en) * | 2007-10-09 | 2014-02-04 | Tufts University | Cholera vaccines |
-
2010
- 2010-09-16 ES ES10817520.9T patent/ES2616912T3/es active Active
- 2010-09-16 PT PT108175209T patent/PT2477649T/pt unknown
- 2010-09-16 PL PL10817520T patent/PL2477649T3/pl unknown
- 2010-09-16 JP JP2012529714A patent/JP2013505017A/ja active Pending
- 2010-09-16 US US13/496,183 patent/US9511133B2/en active Active
- 2010-09-16 CN CN201080041458.1A patent/CN102630166B/zh active Active
- 2010-09-16 IN IN2860DEN2012 patent/IN2012DN02860A/en unknown
- 2010-09-16 EP EP10817520.9A patent/EP2477649B1/en active Active
- 2010-09-16 CA CA2774335A patent/CA2774335C/en active Active
- 2010-09-16 AU AU2010296065A patent/AU2010296065B2/en active Active
- 2010-09-16 WO PCT/SE2010/050996 patent/WO2011034495A1/en active Application Filing
- 2010-09-16 KR KR1020127009647A patent/KR101722802B1/ko active IP Right Grant
- 2010-09-16 HU HUE10817520A patent/HUE031957T2/en unknown
- 2010-09-16 DK DK10817520.9T patent/DK2477649T3/en active
-
2012
- 2012-04-13 ZA ZA2012/02710A patent/ZA201202710B/en unknown
-
2015
- 2015-11-20 JP JP2015227296A patent/JP6178384B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2010296065A1 (en) | 2012-05-10 |
| ZA201202710B (en) | 2015-12-23 |
| KR101722802B1 (ko) | 2017-04-03 |
| JP2013505017A (ja) | 2013-02-14 |
| CN102630166B (zh) | 2015-08-05 |
| KR20120081600A (ko) | 2012-07-19 |
| DK2477649T3 (en) | 2017-03-06 |
| CA2774335C (en) | 2016-10-18 |
| EP2477649A4 (en) | 2013-01-30 |
| EP2477649A1 (en) | 2012-07-25 |
| JP6178384B2 (ja) | 2017-08-09 |
| JP2016074695A (ja) | 2016-05-12 |
| PT2477649T (pt) | 2017-03-01 |
| CN102630166A (zh) | 2012-08-08 |
| CA2774335A1 (en) | 2011-03-24 |
| ES2616912T3 (es) | 2017-06-14 |
| WO2011034495A1 (en) | 2011-03-24 |
| US9511133B2 (en) | 2016-12-06 |
| US20120276146A1 (en) | 2012-11-01 |
| PL2477649T3 (pl) | 2017-06-30 |
| AU2010296065B2 (en) | 2015-05-21 |
| EP2477649B1 (en) | 2016-11-23 |
| HUE031957T2 (en) | 2017-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN02860A (pt) | ||
| SG158154A1 (en) | Methods to elicit, enhance and sustain immune responses against mhc class i-restricted epitopes, for prophylactic or therapeutic purposes | |
| MY172421A (en) | Immunostimulatory oligonucleotides | |
| PH12014501835A1 (en) | Novel adjuvant compositions | |
| WO2006047515A3 (en) | Dendritic cells loaded with heat shocked melanoma cell bodies | |
| EP1872793A4 (en) | POLYAMINO ACID FOR USE AS ADJUVANS | |
| WO2012051211A3 (en) | Antigen delivery platforms | |
| HK1141812A1 (en) | Vaccines based on targeting antigen to dcir expressed an antigen-presenting cells dcir | |
| SG10201405442VA (en) | Method and device for using oxygen in the steam reforming of biomass | |
| IL218447A0 (en) | Co-culture lymphoid tissue equivalent (lte) for an artificial immune system (ais) | |
| IL193397A0 (en) | Hpv antigens, vaccine compositions, and related methods | |
| WO2010148334A3 (en) | Generation of induced pluripotent stem cells from cord blood | |
| WO2010000127A9 (en) | Method to induce and expand therapeutic alloantigen- specific human regulatory t cells in large-scale | |
| WO2009092005A3 (en) | Methods of generating cardiomyocytes and cardiac progenitors and compositions | |
| CA2763359C (en) | New human rotavirus strains and vaccines | |
| EP2496256A4 (en) | IMMUNOCONJUGATES COMPRISING PEPTIDES FROM POXVIRUS AND ANTIBODIES DIRECTED AGAINST ANTIGEN-PRESENTING CELLS FOR SUBUNIT-BASED POXVIRUS VACCINES | |
| NZ715459A (en) | A hyperbarically-inactivated microorganism, immunogenic compositions comprising same and methods for producing same | |
| CL2011000913A1 (es) | Vacuna combinada estable y completamente liquida que comprende antigenos difterico, tetanico, pertusico de celulas completas, y virus de poliomielitis y opcionalmente uno o mas antigenos seleccionados entre haemophilus influenzae y hepatitis; y proceso de fabricacion. | |
| WO2010151517A3 (en) | Antigen-specific long-term memory t-cells | |
| WO2010138750A3 (en) | Generation of genetically corrected disease-free induced pluripotent stem cells | |
| AU2007272785A8 (en) | Methods to elicit, enhance and sustain immune responses against MHC class-I restricted epitopes, for prophylactic or therapeutic purposes | |
| WO2013003899A8 (en) | Methods of treating or preventing rheumatic disease | |
| NZ607792A (en) | Improved vaccine compositions | |
| WO2010006326A3 (en) | Methods and compositions for spore-based vaccines | |
| WO2010110931A3 (en) | Glycoconjugate vaccines |